Proteomic Profiling for Congenital Diaphragmatic Hernia
pro-CDH
Proteomic Analysis of Amniotic Fluid in the Case of Diaphragmatic Hernia: Search for Prognostic Expression Profiles
1 other identifier
observational
10
1 country
2
Brief Summary
Congenital diaphragmatic hernia (CDH) is a severe congenital malformation, related to a developmental defect of the diaphragm. The incidence of CDH is approximated at 1 in 3,000 live births. Although advances in surgery and neonatal intensive care have improved the prognosis, mortality remains high, around 30-50% related to severe lung hypoplasia and persistent pulmonary hypertension. Prenatal evaluation with observed/expected Lung over Head Ratio (o/e LHR), liver position and total lung volume measured by magnetic resonance, have been shown to correlate with neonatal mortality . However, the preponderant factor of persistent pulmonary hypertension remains difficult to predict prenatally. In patients with isolated diaphragmatic hernia (without associated malformations or karyotype abnormalities), prognosis is evaluated indirectly on pulmonary development from pulmonary volume measurements. Apart from the most caricatural cases with extremely good or very pejorative values, for a large proportion of fetuses with diaphragmatic dome hernia the prognosis remains uncertain. The aim of the proposal is to investigate whether the analysis of the proteom of the amniotic fluid of the fetuses with CDH could give information of a prognostic character. The objective of the study is to identify, from the proteomic profile of the amniotic fluid of mothers whose fetus has CDH, prognostic markers candidates for death at 2 months of the infant. The first step is to carry out an exploratory and non-interventional study on a small sample (n = 10) of the target population. This is a preliminary step before considering, if the results are encouraging, a large-scale study from a biological collection to determine candidate proteins (new biomarkers) which relative expression levels could be used as surrogate marker of pulmonary hypoplasia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2017
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 16, 2017
CompletedStudy Start
First participant enrolled
May 18, 2017
CompletedFirst Posted
Study publicly available on registry
June 7, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2019
CompletedJuly 18, 2018
July 1, 2018
2.1 years
May 16, 2017
July 17, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Neonatal death
2 months of age
Secondary Outcomes (13)
Prenatal death of the fetus
9 months
Neonatal death
15 days
Apgar score
5 min after birth
Age at surgery
6 months of age
Need for a diaphragmatic prosthesis
6 months of age
- +8 more secondary outcomes
Study Arms (1)
1
Mothers whose fetus has CDH
Eligibility Criteria
Mothers whose fetus has CDH
You may qualify if:
- Pregnant patients for whom amniocentesis will be performed as part of the prenatal diagnosis of a diaphragmatic hernia.
You may not qualify if:
- Refusal of patients,
- Refusal of spouse regarding data of the future child,
- Multiple malformations,
- Twin pregnancy,
- Prenatal diagnosis of an unconfirmed diaphragmatic hernia,
- Miscarriage after amniocentesis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre Hospitalier Universitaire de Besanconlead
- FEMTO-STcollaborator
Study Sites (2)
CHU de Besançon
Besançon, 25000, France
CHU de Dijon
Dijon, 21000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 16, 2017
First Posted
June 7, 2017
Study Start
May 18, 2017
Primary Completion
July 1, 2019
Study Completion
November 1, 2019
Last Updated
July 18, 2018
Record last verified: 2018-07
Data Sharing
- IPD Sharing
- Will not share